Pay in 4 interest-free payments of $30.00 Learn more
Ships within 48 hours · Estimated delivery Sep 15 - Sep 20
The combination of trastuzumab and Pertuzumab reduces the percentage of proliferating (S-phase) cells by more than 2-fold
+1/p-1/t8-
) dose-dependently attenuates LTD4-induced airway vascular hyperpermeability with complete inhibition at 0
In presence of 1 and 100 nM of piboserod
(±)-Fabesetron hydrochloride Catalog No.:M21705-C The combination of trastuzumab and() Fabesetron hydrochloride (() FK1052) is the racemate of Fabesetron hydrochloride, which is a potent 5 HT3 and 5 HT4 receptor dual antagonist. Product information CAS Number: 129299 81 6 Molecular Weight: 329. 82 Formula: C18H20ClN3O Chemical Name: 10 methyl 7 [(4 methyl 1H imidazol 5 yl)methyl] 6H,7H,8H,9H pyrido[1,2 a]indol 6 one hydrochloride Smiles: Cl. CC1N=CNC=1CC1CCC2=C(C)C3C=CC=CC=3N2C1=O InChiKey: POKFYJWUPWZYQV UHFFFAOYSA N InChi: InChI=1S
US$ 75.00
US$ 38.00
US$ 75.00
US$ 36.00
US$ 75.00